06/26/25
Allen Ho, MD named to Nanoscope Therapeutics Visionary Advisory Committee
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative diseases, today announced the formation of its Visionary Advisory Committee (VAC). The group of renowned experts in retina treatment and commercialization included Wills Eye Director of Retina Research Allen C. Ho, MD.